The supplement industry on Wednesday called into question the validity of the New York Attorney General's investigtation into botanical dietary supplements with a white paper that outlines the potential shortfalls of the testing methodology used.
Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.
Miraculins in January announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario beginning in February.
In a meeting with nearly two dozen leaders representing consumers, insurers, providers and business leaders, Health and Human Services Secretary Sylvia Burwell on Jan. 26 announced measurable goals and a timeline to move the Medicare program, and the healthcare system at large, toward paying providers based on the quality of care they give patients.
The introduction in January of bipartisan legislation that would grant retail pharmacists provider status for Medicare patients in “underserved” communities certainly sounds like a step in the right direction.